BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31513033)

  • 1. Overview of breast cancer.
    Watkins EJ
    JAAPA; 2019 Oct; 32(10):13-17. PubMed ID: 31513033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chinese expert consensus on the diagnosis and treatment of breast carcinoma in situ].
    Sun Q; Xu BH; Shao ZM;
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):942-947. PubMed ID: 27998472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2004.
    Kinoshita T; Fukui N; Anan K; Iwamoto T; Niikura N; Kawai M; Hayashi N; Tsugawa K; Aogi K; Ishida T; Masuoka H; Masuda S; Iijima K; Nakamura S; Tokuda Y
    Breast Cancer; 2016 Jan; 23(1):39-49. PubMed ID: 26446041
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a low-grade precursor pathway in breast cancer?
    King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer.
    Cefaro GA; Genovesi D; Trignani M; DI Nicola M
    Anticancer Res; 2014 Mar; 34(3):1207-12. PubMed ID: 24596361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
    Coates AS; Winer EP; Goldhirsch A; Gelber RD; Gnant M; Piccart-Gebhart M; Thürlimann B; Senn HJ;
    Ann Oncol; 2015 Aug; 26(8):1533-46. PubMed ID: 25939896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubular carcinoma of the breast: institutional and SEER database analysis supporting a unique classification.
    Romano AM; Wages NA; Smolkin M; Fortune KL; Atkins K; Dillon PM
    Breast Dis; 2015; 35(2):103-11. PubMed ID: 25567000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres.
    Angarita FA; Chesney T; Elser C; Mulligan AM; McCready DR; Escallon J
    Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features.
    Calvo-Plaza I; Ugidos L; Miró C; Quevedo P; Parras M; Márquez C; de la Cruz JJ; Suárez-Gauthier A; Pérez FJ; Herrero M; Marcos M; García-Aranda M; Hidalgo M; Estévez LG
    Clin Transl Oncol; 2013 Mar; 15(3):205-10. PubMed ID: 22872518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality indicators for the care of breast cancer in vulnerable elders.
    Naeim A; Sawhney R; MacLean CH; Sanati H
    J Am Geriatr Soc; 2007 Oct; 55 Suppl 2():S258-69. PubMed ID: 17910546
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
    Amirifard N; Sadeghi E
    Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast cancers: unique clinical presentations and outcomes.
    Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological characteristics of breast cancer.
    Kocic B; Filipovic S; Petrovic B; Mijalkovic D; Rancic N; Poultsidi A
    J BUON; 2010; 15(4):660-7. PubMed ID: 21229626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
    Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
    Nye L; Rademaker A; Gradishar WJ
    Clin Breast Cancer; 2017 Jul; 17(4):e185-e189. PubMed ID: 28185739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
    Doebar SC; Slaets L; Cardoso F; Giordano SH; Bartlett JM; Tryfonidis K; Dijkstra NH; Schröder CP; van Asperen CJ; Linderholm B; Benstead K; Dinjens WN; van Marion R; van Diest PJ; Martens JW; van Deurzen CH
    Mod Pathol; 2017 Apr; 30(4):509-518. PubMed ID: 28084333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
    Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
    Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
    Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
    Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.